Abeona Therapeutics Inc
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -3.2% | +16.9% | +79.1% | -10.0% | -9.7% | -8.8% | +147.8% | -6.1% | -5.0% | -9.6% | -9.6% | |
| – | -2.7% | +19.7% | +88.7% | -10.5% | -10.5% | -12.6% | +163.6% | -6.9% | -5.2% | -10.7% | -10.1% | |
| – | +207.2% | +21.3% | +96.1% | -54.3% | +48.5% | -31.8% | +926.2% | -49.1% | -5.7% | -21.8% | -8.4% | |
| – | -2.8% | +19.4% | +96.8% | -10.6% | -10.9% | -13.9% | +168.0% | -8.0% | -7.7% | -12.1% | -12.7% | |
| – | +10.6% | -8.7% | -26.5% | -1.6% | +2.4% | -2.1% | +0.8% | -0.9% | +315.5% | -0.1% | +47.4% | |
| – | – | – | – | – | – | – | – | +80.6% | +13.3% | +10.2% | -2.2% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +11.6% | +70.2% | -27.4% | +23.1% | -13.3% | -10.7% | +42.6% | -27.6% | +0.8% | -11.3% | -3.9% | |
| – | +59.6% | -11.4% | +41.7% | +9.4% | -10.0% | +8.4% | +91.9% | -35.7% | +33.3% | +5.0% | -20.1% | |
| – | -39.5% | +4.6% | +284.5% | +37.0% | +22.7% | +29.8% | -30.5% | +47.6% | +45.5% | +11.6% | +0.1% | |
| – | -28.3% | +80.9% | -7.8% | -10.0% | +23.4% | +45.8% | +46.2% | -19.2% | +33.1% | -48.4% | -26.5% | |
| – | – | – | -10.8% | -11.9% | -8.2% | -14.6% | +25.7% | -22.4% | -28.1% | -39.2% | -65.2% | |
| – | -32.7% | -159.9% | – | -37.5% | -3.8% | -6.0% | +295.1% | +4.7% | -7.0% | -9.0% | -11.6% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +3.1% | +6.9% | +87.5% | -6.1% | -14.6% | +21.3% | +33.9% | -18.6% | +21.9% | -14.4% | +0.8% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.